跳至主要内容
临床试验/NCT04220294
NCT04220294已完成不适用

Surgical Site Infection Rate After Subcutaneous Continuous Versus Interrupted Sutures During Cesarean Section.

Rambam Health Care Campus1 个研究点 分布在 1 个国家目标入组 1,238 人开始时间: 2020年1月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
1,238
试验地点
1
主要终点
Surgical site infection rate.

研究概览

简要总结

A comparison of the rate of surgical site infections after cesarean section depending on the type of suture used for subcutaneous closure-continuous versus interrupted.

详细描述

Patients at term that are candidates for elective cesarean section will receive an explanation regarding the study and sign informed consent. Patients will then be divided randomly to one of 2 treatment groups based on the type of subcutaneous tissue closure:

  1. Interrupted sutures.
  2. Continuous sutures. Information regarding medical and obstetric history will be collected for each patient.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Pregnant women undergoing elective cesarean section.
  • •Subcutaneous tissue layer>2 centimeter according to ultrasound.

排除标准

  • •Non-elective CS.
  • •Fever during the 48 hours prior to surgery.
  • •Antibiotic treatment during the 48 hours prior to surgery.
  • •Inability to give informed consent.
  • •Preterm delivery (< 37 weeks' gestation).
  • •Fetal death.
  • •Known fetal anomalies or placental abnormalities.
  • •Immunosuppressive conditions.

研究组 & 干预措施

Interrupted sutures

Active Comparator

Subcutaneous tissue closure by interrupted sutures.

干预措施: Subcutaneous tissue closure (Procedure)

Continuous sutures

Active Comparator

Subcutaneous tissue closure by continuous sutures.

干预措施: Subcutaneous tissue closure (Procedure)

结局指标

主要结局

Surgical site infection rate.

时间窗: From admission up to 6 weeks postpartum.

Surgical site infection rate.

次要结局

  • Rate of re-admission due to surgical site infection.(From admission up to 6 weeks postpartum.)
  • Rate of postoperative febrile morbidity.(From admission up to 6 weeks postpartum.)
  • Rate of maternal fever.(From admission up to 6 weeks postpartum.)
  • Duration of maternal fever.(From admission up to 6 weeks postpartum.)
  • Rate of antibiotic use for the treatment of surgical site infection.(From admission up to 6 weeks postpartum.)
  • Cesraean section-to-surgical site infection time interval.(From admission up to 6 weeks postpartum.)
  • Rate of bacteremia.(From admission up to 6 weeks postpartum.)
  • Rate of sepsis.(From admission up to 6 weeks postpartum.)
  • Post-operative duration of hospitalization.(From admission up to 6 weeks postpartum.)
  • Postoperative pain.(From admission up to 6 weeks postpartum.)
  • Rate of postoperative anemia.(From admission up to 6 weeks postpartum.)
  • Blood transfusion rates.(From admission up to 6 weeks postpartum.)
  • Breastfeeding rates.(From admission up to 6 weeks postpartum.)
  • rate of voiding problems.(From admission up to 6 weeks postpartum.)
  • Venous thromboembolism rates.(From admission up to 6 weeks postpartum.)
  • Rate of admission to intensive care unit.(From admission up to 6 weeks postpartum.)
  • Maternal death rate(From admission up to 6 weeks postpartum.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

ROY LAUTERBACH MD

Principal investigator

Rambam Health Care Campus

研究点 (1)

Loading locations...

相似试验